Dyno Therapeutics, a privately-held US genetic technologies company applying AI to enable in vivo gene delivery, has ...

French independent pharma company Servier says it has appointed David Lee to its executive committee as executive vice ...

US fibrosis-focused drug developer Mediar Therapeutics has entered into global licensing agreement with US pharma major Eli ...

Medicines Discovery Catapult (MDC), the UK government-backed life sciences service dedicated to driving productivity and ...

California-based immunology start-up Ouro Medicines, which is developing immune reset therapeutics for people living with ...

US radiopharmaceuticals-focused Lantheus Holdings today announced a definitive agreement to acquire Life Molecular Imaging.

UK pharma major GSK is to acquire IDRx, a Boston, USA-based, clinical-stage biopharma developing precision therapeutics for ...

Shares of USA-based Intra-Cellular Therapies leapt almost 36% to $128.85 in pre-marker activity today, as rumors of a ...

Real-world evidence (RWE) specialist Atropos Health has announced a collaboration with US pharma giant Merck & Co.

CNX Therapeutics partners with Klaria Pharma to market sumatriptan alginate film in Europe, addressing critical migraine ...

Aragen Life Sciences secures $100M investment from Quadria Capital, valuing the CRDMO at $1.4B. The funding supports ...

Teva partners with Klinge Biopharma and Formycon to commercialize FYB203, an Eylea biosimilar, as Ahzantive in Europe and ...